| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiology | 40 | 2024 | 2090 | 5.810 |
Why?
|
| Radiology Department, Hospital | 15 | 2021 | 407 | 4.720 |
Why?
|
| Quality Assurance, Health Care | 21 | 2015 | 2172 | 2.390 |
Why?
|
| Diagnostic Errors | 10 | 2024 | 1275 | 2.150 |
Why?
|
| Peer Review | 7 | 2020 | 217 | 2.090 |
Why?
|
| Burnout, Professional | 4 | 2023 | 711 | 1.530 |
Why?
|
| Quality Improvement | 11 | 2018 | 3853 | 1.320 |
Why?
|
| Employee Performance Appraisal | 3 | 2018 | 86 | 1.100 |
Why?
|
| Leadership | 6 | 2020 | 1392 | 1.090 |
Why?
|
| Professional Practice | 3 | 2018 | 313 | 0.980 |
Why?
|
| Practice Management, Medical | 2 | 2018 | 191 | 0.960 |
Why?
|
| Job Satisfaction | 2 | 2018 | 549 | 0.930 |
Why?
|
| Tomography, X-Ray Computed | 50 | 2012 | 20659 | 0.900 |
Why?
|
| Risk Management | 6 | 2015 | 559 | 0.870 |
Why?
|
| Interprofessional Relations | 3 | 2021 | 999 | 0.780 |
Why?
|
| Medical Errors | 8 | 2021 | 1260 | 0.780 |
Why?
|
| Liver Neoplasms | 22 | 2009 | 4353 | 0.770 |
Why?
|
| Diagnostic Imaging | 10 | 2017 | 3529 | 0.750 |
Why?
|
| Liver Circulation | 7 | 2004 | 163 | 0.740 |
Why?
|
| Radiography, Abdominal | 4 | 2023 | 544 | 0.730 |
Why?
|
| Joint Commission on Accreditation of Healthcare Organizations | 4 | 2018 | 91 | 0.710 |
Why?
|
| Liver | 24 | 2007 | 7562 | 0.710 |
Why?
|
| Credentialing | 3 | 2018 | 118 | 0.620 |
Why?
|
| Radiology, Interventional | 3 | 2022 | 485 | 0.620 |
Why?
|
| Safety Management | 5 | 2015 | 763 | 0.620 |
Why?
|
| Peer Review, Health Care | 2 | 2016 | 73 | 0.610 |
Why?
|
| Patient-Centered Care | 2 | 2018 | 1458 | 0.600 |
Why?
|
| Mammary Neoplasms, Experimental | 8 | 2008 | 498 | 0.600 |
Why?
|
| Ultrasonography | 20 | 2011 | 5993 | 0.580 |
Why?
|
| Database Management Systems | 2 | 2017 | 263 | 0.560 |
Why?
|
| Contrast Media | 17 | 2011 | 5329 | 0.550 |
Why?
|
| Clinical Competence | 6 | 2017 | 4863 | 0.540 |
Why?
|
| Checklist | 2 | 2022 | 848 | 0.540 |
Why?
|
| Health Promotion | 2 | 2018 | 2208 | 0.530 |
Why?
|
| Professional-Patient Relations | 1 | 2021 | 721 | 0.530 |
Why?
|
| Colonography, Computed Tomographic | 7 | 2009 | 170 | 0.510 |
Why?
|
| Models, Organizational | 4 | 2015 | 547 | 0.510 |
Why?
|
| Organizational Objectives | 3 | 2015 | 426 | 0.500 |
Why?
|
| Radiology Information Systems | 4 | 2017 | 532 | 0.500 |
Why?
|
| Radiography | 7 | 2020 | 6919 | 0.500 |
Why?
|
| Ultrasonography, Interventional | 10 | 2009 | 1531 | 0.490 |
Why?
|
| Angiography | 8 | 2008 | 1581 | 0.480 |
Why?
|
| Catheter Ablation | 16 | 2006 | 2788 | 0.460 |
Why?
|
| Episode of Care | 1 | 2015 | 128 | 0.460 |
Why?
|
| Cultural Diversity | 1 | 2018 | 370 | 0.450 |
Why?
|
| Neovascularization, Pathologic | 4 | 2008 | 2631 | 0.440 |
Why?
|
| Rectal Diseases | 2 | 2008 | 141 | 0.440 |
Why?
|
| Oxides | 4 | 2008 | 402 | 0.430 |
Why?
|
| Doxorubicin | 9 | 2003 | 2230 | 0.420 |
Why?
|
| Vulnerable Populations | 1 | 2018 | 718 | 0.410 |
Why?
|
| Living Donors | 9 | 2008 | 645 | 0.400 |
Why?
|
| Cholecystitis, Acute | 2 | 2011 | 81 | 0.400 |
Why?
|
| Liver Transplantation | 16 | 2008 | 2412 | 0.400 |
Why?
|
| Liver Neoplasms, Experimental | 3 | 2000 | 190 | 0.390 |
Why?
|
| Humans | 151 | 2024 | 765968 | 0.380 |
Why?
|
| United States | 26 | 2023 | 72903 | 0.370 |
Why?
|
| Radiographic Image Enhancement | 5 | 2007 | 872 | 0.370 |
Why?
|
| Minority Groups | 1 | 2018 | 1207 | 0.370 |
Why?
|
| Writing | 1 | 2013 | 199 | 0.360 |
Why?
|
| Organizational Culture | 3 | 2020 | 514 | 0.350 |
Why?
|
| Efficiency, Organizational | 3 | 2011 | 697 | 0.340 |
Why?
|
| Emotions | 1 | 2021 | 2763 | 0.330 |
Why?
|
| Hepatectomy | 6 | 2006 | 589 | 0.330 |
Why?
|
| Abdominal Neoplasms | 3 | 2008 | 284 | 0.330 |
Why?
|
| Image Enhancement | 5 | 2008 | 2858 | 0.320 |
Why?
|
| Intraoperative Care | 4 | 2006 | 760 | 0.320 |
Why?
|
| Occupational Health | 2 | 2013 | 813 | 0.320 |
Why?
|
| Defecography | 1 | 2008 | 17 | 0.320 |
Why?
|
| Electronic Mail | 1 | 2010 | 216 | 0.310 |
Why?
|
| Health Care Reform | 2 | 2015 | 1259 | 0.310 |
Why?
|
| Anus Diseases | 1 | 2008 | 53 | 0.310 |
Why?
|
| Quality Indicators, Health Care | 2 | 2017 | 1806 | 0.310 |
Why?
|
| Adnexal Diseases | 1 | 2009 | 104 | 0.300 |
Why?
|
| Appendicitis | 2 | 2006 | 679 | 0.290 |
Why?
|
| Practice Guidelines as Topic | 7 | 2012 | 7425 | 0.290 |
Why?
|
| Colorectal Neoplasms | 11 | 2007 | 6942 | 0.290 |
Why?
|
| Data Collection | 2 | 2014 | 3318 | 0.290 |
Why?
|
| Angiogenesis Inhibitors | 3 | 2008 | 2056 | 0.280 |
Why?
|
| Adenocarcinoma | 8 | 2007 | 6364 | 0.280 |
Why?
|
| Endosonography | 3 | 2010 | 626 | 0.280 |
Why?
|
| Publishing | 2 | 2014 | 835 | 0.270 |
Why?
|
| Workflow | 1 | 2012 | 862 | 0.270 |
Why?
|
| Cognition | 1 | 2024 | 7049 | 0.270 |
Why?
|
| Accreditation | 2 | 2011 | 477 | 0.270 |
Why?
|
| Halothane | 4 | 2004 | 200 | 0.260 |
Why?
|
| Documentation | 1 | 2013 | 916 | 0.260 |
Why?
|
| Guidelines as Topic | 1 | 2013 | 1394 | 0.260 |
Why?
|
| Societies, Medical | 6 | 2023 | 3956 | 0.260 |
Why?
|
| Cholecystostomy | 2 | 2004 | 54 | 0.260 |
Why?
|
| Iron | 3 | 2008 | 1816 | 0.260 |
Why?
|
| Image Processing, Computer-Assisted | 11 | 2007 | 8923 | 0.260 |
Why?
|
| Fecal Incontinence | 1 | 2008 | 245 | 0.250 |
Why?
|
| Online Systems | 1 | 2006 | 181 | 0.250 |
Why?
|
| Colitis, Ischemic | 1 | 2005 | 32 | 0.250 |
Why?
|
| Osteomyelitis | 2 | 2008 | 408 | 0.250 |
Why?
|
| Appendix | 1 | 2006 | 109 | 0.250 |
Why?
|
| Cholecystitis | 2 | 2004 | 181 | 0.250 |
Why?
|
| Teleradiology | 1 | 2005 | 52 | 0.240 |
Why?
|
| Surgery, Computer-Assisted | 3 | 2010 | 993 | 0.240 |
Why?
|
| Faculty, Medical | 1 | 2013 | 1219 | 0.240 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2008 | 548 | 0.240 |
Why?
|
| Quality of Health Care | 2 | 2018 | 4300 | 0.240 |
Why?
|
| Workplace | 3 | 2020 | 873 | 0.230 |
Why?
|
| Occupational Diseases | 1 | 2013 | 1456 | 0.230 |
Why?
|
| Colonic Polyps | 5 | 2003 | 556 | 0.230 |
Why?
|
| Information Dissemination | 1 | 2013 | 1142 | 0.230 |
Why?
|
| Radiography, Interventional | 5 | 2006 | 1129 | 0.230 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 3475 | 0.230 |
Why?
|
| Magnetic Resonance Imaging | 16 | 2010 | 36532 | 0.220 |
Why?
|
| Liver Diseases | 7 | 2009 | 1303 | 0.220 |
Why?
|
| Hepatic Artery | 7 | 2004 | 231 | 0.220 |
Why?
|
| Constipation | 1 | 2008 | 568 | 0.220 |
Why?
|
| Pancreatic Neoplasms | 6 | 2007 | 5444 | 0.220 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2007 | 445 | 0.220 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2007 | 512 | 0.210 |
Why?
|
| Colonic Diseases | 2 | 2007 | 204 | 0.210 |
Why?
|
| Hepatic Veins | 6 | 2004 | 112 | 0.210 |
Why?
|
| Ultrasonography, Doppler | 3 | 2008 | 460 | 0.210 |
Why?
|
| Biliary Tract | 2 | 2001 | 137 | 0.210 |
Why?
|
| Microscopy, Fluorescence | 6 | 2007 | 2627 | 0.210 |
Why?
|
| Internship and Residency | 4 | 2013 | 5946 | 0.210 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2004 | 235 | 0.210 |
Why?
|
| Preoperative Care | 7 | 2007 | 2267 | 0.210 |
Why?
|
| X-Rays | 1 | 2023 | 310 | 0.200 |
Why?
|
| Forecasting | 4 | 2023 | 2936 | 0.200 |
Why?
|
| Occupational Exposure | 1 | 2013 | 1805 | 0.200 |
Why?
|
| Pancreatectomy | 2 | 2021 | 820 | 0.200 |
Why?
|
| Hemangiopericytoma | 1 | 2002 | 71 | 0.200 |
Why?
|
| Theft | 1 | 2021 | 20 | 0.200 |
Why?
|
| Antigens | 5 | 1992 | 1438 | 0.190 |
Why?
|
| Spinal Diseases | 1 | 2007 | 559 | 0.190 |
Why?
|
| Colonoscopy | 5 | 2007 | 1406 | 0.190 |
Why?
|
| User-Computer Interface | 6 | 2007 | 1405 | 0.190 |
Why?
|
| Rectal Neoplasms | 3 | 2002 | 1182 | 0.190 |
Why?
|
| Rectal Fistula | 1 | 2001 | 76 | 0.180 |
Why?
|
| Running | 1 | 2005 | 488 | 0.180 |
Why?
|
| Paraneoplastic Syndromes | 1 | 2002 | 156 | 0.180 |
Why?
|
| Brain Diseases | 2 | 2007 | 1546 | 0.180 |
Why?
|
| Internet | 5 | 2021 | 3106 | 0.180 |
Why?
|
| Attitude of Health Personnel | 2 | 2015 | 3925 | 0.180 |
Why?
|
| Mice, Nude | 9 | 2007 | 3618 | 0.170 |
Why?
|
| Microscopy, Video | 6 | 2004 | 241 | 0.170 |
Why?
|
| Delivery of Health Care | 2 | 2015 | 5370 | 0.170 |
Why?
|
| Bile Ducts | 1 | 2001 | 288 | 0.170 |
Why?
|
| Certification | 2 | 2015 | 416 | 0.170 |
Why?
|
| Portal Vein | 8 | 2004 | 435 | 0.170 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 5 | 1992 | 428 | 0.170 |
Why?
|
| Communication | 2 | 2012 | 3916 | 0.170 |
Why?
|
| Venereal Tumors, Veterinary | 3 | 2004 | 8 | 0.160 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2006 | 700 | 0.160 |
Why?
|
| Privacy | 1 | 2021 | 233 | 0.160 |
Why?
|
| Referral and Consultation | 3 | 2010 | 3615 | 0.160 |
Why?
|
| Chest Pain | 1 | 2006 | 1100 | 0.160 |
Why?
|
| Chemoembolization, Therapeutic | 3 | 1996 | 129 | 0.160 |
Why?
|
| Group Processes | 1 | 2020 | 224 | 0.150 |
Why?
|
| Carcinoma, Hepatocellular | 5 | 2006 | 2329 | 0.150 |
Why?
|
| Male | 74 | 2021 | 363698 | 0.150 |
Why?
|
| Adenomatous Polyps | 1 | 1999 | 109 | 0.150 |
Why?
|
| Portal Pressure | 1 | 1998 | 62 | 0.150 |
Why?
|
| Hydrogen Peroxide | 1 | 2001 | 743 | 0.150 |
Why?
|
| Sensitivity and Specificity | 14 | 2009 | 14652 | 0.140 |
Why?
|
| Patient Selection | 5 | 2007 | 4255 | 0.140 |
Why?
|
| Rats, Inbred F344 | 6 | 2007 | 822 | 0.140 |
Why?
|
| Research Report | 1 | 2020 | 367 | 0.140 |
Why?
|
| Female | 69 | 2021 | 396112 | 0.140 |
Why?
|
| Blood Flow Velocity | 3 | 2007 | 1381 | 0.140 |
Why?
|
| Rectum | 3 | 2002 | 896 | 0.140 |
Why?
|
| Feedback, Psychological | 1 | 2017 | 97 | 0.140 |
Why?
|
| Patient Access to Records | 1 | 2018 | 120 | 0.130 |
Why?
|
| Pandemics | 3 | 2021 | 8703 | 0.130 |
Why?
|
| Equipment Design | 6 | 2008 | 3481 | 0.130 |
Why?
|
| Choristoma | 2 | 2010 | 206 | 0.130 |
Why?
|
| Intestinal Obstruction | 1 | 2000 | 432 | 0.130 |
Why?
|
| Pelvis | 2 | 2014 | 738 | 0.130 |
Why?
|
| Education, Medical, Continuing | 1 | 2021 | 830 | 0.130 |
Why?
|
| Ferrosoferric Oxide | 3 | 2008 | 349 | 0.130 |
Why?
|
| Disease Models, Animal | 6 | 2007 | 18293 | 0.130 |
Why?
|
| Antineoplastic Agents | 8 | 2008 | 13648 | 0.120 |
Why?
|
| Biliary Tract Neoplasms | 1 | 1997 | 186 | 0.120 |
Why?
|
| Data Display | 3 | 2012 | 174 | 0.120 |
Why?
|
| Hypoglycemia | 1 | 2002 | 896 | 0.120 |
Why?
|
| Colonic Neoplasms | 4 | 2012 | 2531 | 0.120 |
Why?
|
| Rats | 18 | 2008 | 23707 | 0.120 |
Why?
|
| Animals | 42 | 2008 | 168764 | 0.120 |
Why?
|
| Professional Competence | 2 | 2009 | 429 | 0.120 |
Why?
|
| Education, Medical, Graduate | 1 | 2007 | 2418 | 0.120 |
Why?
|
| Neoplasm Transplantation | 6 | 2004 | 2014 | 0.110 |
Why?
|
| Anesthetics, Inhalation | 2 | 2004 | 573 | 0.110 |
Why?
|
| Granuloma, Plasma Cell | 2 | 2009 | 80 | 0.110 |
Why?
|
| Physician-Patient Relations | 2 | 2018 | 3278 | 0.110 |
Why?
|
| Acute Disease | 4 | 2006 | 7232 | 0.110 |
Why?
|
| Pancreatic Diseases | 2 | 2010 | 353 | 0.110 |
Why?
|
| Daunorubicin | 1 | 1993 | 157 | 0.110 |
Why?
|
| Specialty Boards | 1 | 2015 | 234 | 0.110 |
Why?
|
| Spinal Cord Diseases | 2 | 2007 | 290 | 0.110 |
Why?
|
| Pancreas | 2 | 2010 | 1700 | 0.110 |
Why?
|
| Cerebrospinal Fluid | 2 | 2007 | 539 | 0.110 |
Why?
|
| Fluoroscopy | 2 | 2008 | 947 | 0.110 |
Why?
|
| Risk Assessment | 7 | 2020 | 24282 | 0.100 |
Why?
|
| United States Occupational Safety and Health Administration | 1 | 2013 | 54 | 0.100 |
Why?
|
| Adult | 45 | 2021 | 223044 | 0.100 |
Why?
|
| Rabbits | 4 | 2008 | 4734 | 0.100 |
Why?
|
| Electrocardiography | 1 | 2006 | 6404 | 0.100 |
Why?
|
| Tomography, Spiral Computed | 2 | 2006 | 273 | 0.100 |
Why?
|
| Fibrin | 4 | 1993 | 513 | 0.100 |
Why?
|
| Needs Assessment | 1 | 2018 | 1138 | 0.100 |
Why?
|
| Pulmonary Embolism | 1 | 2006 | 2598 | 0.100 |
Why?
|
| Cost Control | 1 | 2015 | 624 | 0.100 |
Why?
|
| Needlestick Injuries | 1 | 2013 | 71 | 0.100 |
Why?
|
| Radiation Dosage | 3 | 2013 | 1944 | 0.100 |
Why?
|
| Middle Aged | 45 | 2021 | 223009 | 0.100 |
Why?
|
| Aged, 80 and over | 22 | 2014 | 59489 | 0.100 |
Why?
|
| Necrosis | 5 | 2004 | 1617 | 0.100 |
Why?
|
| Abdominal Abscess | 2 | 2006 | 152 | 0.100 |
Why?
|
| Retrospective Studies | 16 | 2021 | 81514 | 0.100 |
Why?
|
| Coronary Vessel Anomalies | 1 | 1995 | 307 | 0.100 |
Why?
|
| Barium Sulfate | 3 | 2008 | 180 | 0.100 |
Why?
|
| Private Sector | 1 | 2015 | 396 | 0.100 |
Why?
|
| Remedial Teaching | 1 | 2011 | 16 | 0.100 |
Why?
|
| Eledoisin | 1 | 1991 | 2 | 0.090 |
Why?
|
| Software Design | 1 | 2012 | 173 | 0.090 |
Why?
|
| Neurokinin A | 1 | 1991 | 32 | 0.090 |
Why?
|
| Antibiotics, Antineoplastic | 3 | 2003 | 679 | 0.090 |
Why?
|
| Statistics, Nonparametric | 3 | 2009 | 2844 | 0.090 |
Why?
|
| Aged | 35 | 2021 | 171117 | 0.090 |
Why?
|
| Product Labeling | 1 | 2012 | 75 | 0.090 |
Why?
|
| Neoplasms | 4 | 2012 | 22340 | 0.090 |
Why?
|
| Magnetite Nanoparticles | 2 | 2008 | 309 | 0.090 |
Why?
|
| Kidney Neoplasms | 3 | 2004 | 4274 | 0.090 |
Why?
|
| Saline Solution, Hypertonic | 2 | 2002 | 116 | 0.090 |
Why?
|
| Intraoperative Period | 2 | 2007 | 508 | 0.090 |
Why?
|
| Amino Acids, Essential | 1 | 1991 | 26 | 0.090 |
Why?
|
| Biopsy, Needle | 2 | 2009 | 1628 | 0.090 |
Why?
|
| Dextrans | 2 | 2008 | 571 | 0.090 |
Why?
|
| Ethiodized Oil | 3 | 1996 | 27 | 0.090 |
Why?
|
| Neurokinin B | 1 | 1991 | 67 | 0.090 |
Why?
|
| Observer Variation | 3 | 2009 | 2615 | 0.090 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 4 | 1992 | 1724 | 0.090 |
Why?
|
| Neoplasm Staging | 5 | 2007 | 11206 | 0.080 |
Why?
|
| Boston | 3 | 2013 | 9338 | 0.080 |
Why?
|
| Substance P | 1 | 1991 | 331 | 0.080 |
Why?
|
| Software | 5 | 2007 | 4462 | 0.080 |
Why?
|
| Health Care Surveys | 1 | 2017 | 2424 | 0.080 |
Why?
|
| Biliary Tract Diseases | 2 | 2001 | 160 | 0.080 |
Why?
|
| Patient Care Team | 2 | 2020 | 2517 | 0.080 |
Why?
|
| Diagnosis, Differential | 9 | 2010 | 12976 | 0.080 |
Why?
|
| Curriculum | 3 | 2008 | 3782 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 5 | 2002 | 6113 | 0.080 |
Why?
|
| Hyperthermia, Induced | 2 | 2004 | 415 | 0.080 |
Why?
|
| Consensus | 1 | 2018 | 3202 | 0.080 |
Why?
|
| Efficiency | 1 | 2012 | 480 | 0.080 |
Why?
|
| Mandatory Reporting | 1 | 2009 | 123 | 0.080 |
Why?
|
| Mice | 14 | 2008 | 81819 | 0.080 |
Why?
|
| Inflammation | 1 | 2008 | 10850 | 0.080 |
Why?
|
| Serum Albumin | 2 | 1991 | 675 | 0.080 |
Why?
|
| Colon | 3 | 2002 | 1795 | 0.070 |
Why?
|
| Microcirculation | 5 | 2001 | 1280 | 0.070 |
Why?
|
| Diabetes Complications | 1 | 1995 | 1316 | 0.070 |
Why?
|
| Task Performance and Analysis | 1 | 2012 | 770 | 0.070 |
Why?
|
| Intestinal Perforation | 1 | 2009 | 253 | 0.070 |
Why?
|
| Benzenesulfonates | 1 | 2008 | 170 | 0.070 |
Why?
|
| Electrophoresis, Disc | 1 | 1987 | 66 | 0.070 |
Why?
|
| Feedback | 1 | 2011 | 796 | 0.070 |
Why?
|
| Coronary Disease | 2 | 1995 | 5912 | 0.070 |
Why?
|
| Databases, Bibliographic | 1 | 2007 | 128 | 0.070 |
Why?
|
| HT29 Cells | 1 | 2007 | 187 | 0.070 |
Why?
|
| Triiodobenzoic Acids | 2 | 2011 | 124 | 0.070 |
Why?
|
| Perfusion | 4 | 2008 | 1407 | 0.070 |
Why?
|
| Microbubbles | 1 | 2008 | 136 | 0.070 |
Why?
|
| Splanchnic Circulation | 1 | 2007 | 122 | 0.070 |
Why?
|
| Fluorescence | 2 | 2007 | 753 | 0.070 |
Why?
|
| Goals | 1 | 2012 | 719 | 0.070 |
Why?
|
| Learning | 1 | 2016 | 1755 | 0.070 |
Why?
|
| Phlebography | 1 | 2007 | 328 | 0.070 |
Why?
|
| Combined Modality Therapy | 6 | 2003 | 8529 | 0.060 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2001 | 3181 | 0.060 |
Why?
|
| Liposomes | 4 | 2002 | 788 | 0.060 |
Why?
|
| Paracentesis | 1 | 2006 | 99 | 0.060 |
Why?
|
| Reimbursement Mechanisms | 1 | 2011 | 672 | 0.060 |
Why?
|
| Transducers | 2 | 2004 | 239 | 0.060 |
Why?
|
| Infection Control | 1 | 2013 | 983 | 0.060 |
Why?
|
| Portasystemic Shunt, Surgical | 2 | 1995 | 40 | 0.060 |
Why?
|
| Leukemia, Myelomonocytic, Acute | 1 | 2005 | 38 | 0.060 |
Why?
|
| Computer Graphics | 1 | 2007 | 344 | 0.060 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2015 | 1188 | 0.060 |
Why?
|
| Cecum | 1 | 2005 | 232 | 0.060 |
Why?
|
| Equipment Safety | 2 | 2003 | 250 | 0.060 |
Why?
|
| Quality Control | 1 | 2008 | 837 | 0.060 |
Why?
|
| Fibrinogen | 2 | 1993 | 895 | 0.060 |
Why?
|
| Artifacts | 3 | 2006 | 1893 | 0.060 |
Why?
|
| Information Storage and Retrieval | 2 | 2007 | 834 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 2 | 2007 | 3602 | 0.060 |
Why?
|
| Injections, Intravenous | 6 | 2003 | 1377 | 0.060 |
Why?
|
| Kidney Diseases | 2 | 2011 | 2098 | 0.060 |
Why?
|
| Educational Measurement | 1 | 2011 | 1260 | 0.060 |
Why?
|
| Sarcoma, Experimental | 1 | 2004 | 116 | 0.060 |
Why?
|
| Para-Aortic Bodies | 1 | 2003 | 3 | 0.060 |
Why?
|
| Photography | 1 | 2007 | 533 | 0.060 |
Why?
|
| Neoplasms, Nerve Tissue | 1 | 2003 | 20 | 0.060 |
Why?
|
| Hemorheology | 1 | 2004 | 144 | 0.050 |
Why?
|
| Regional Blood Flow | 2 | 2004 | 1478 | 0.050 |
Why?
|
| Spectroscopy, Near-Infrared | 2 | 2007 | 750 | 0.050 |
Why?
|
| Diagnosis | 1 | 2004 | 158 | 0.050 |
Why?
|
| Acetic Acid | 1 | 2003 | 58 | 0.050 |
Why?
|
| Paraganglioma, Extra-Adrenal | 1 | 2003 | 47 | 0.050 |
Why?
|
| Drainage | 2 | 2006 | 1179 | 0.050 |
Why?
|
| Diverticulitis | 1 | 2006 | 187 | 0.050 |
Why?
|
| Physical Endurance | 1 | 2005 | 368 | 0.050 |
Why?
|
| Bile | 1 | 2004 | 300 | 0.050 |
Why?
|
| Ascites | 1 | 2005 | 336 | 0.050 |
Why?
|
| Hidrocystoma | 1 | 2002 | 10 | 0.050 |
Why?
|
| Salivary Glands | 1 | 2004 | 231 | 0.050 |
Why?
|
| Kupffer Cells | 3 | 1998 | 144 | 0.050 |
Why?
|
| Gallbladder | 1 | 2004 | 308 | 0.050 |
Why?
|
| Dog Diseases | 1 | 2003 | 142 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3100 | 0.050 |
Why?
|
| Reimbursement, Incentive | 1 | 2008 | 541 | 0.050 |
Why?
|
| Gallbladder Neoplasms | 1 | 2004 | 189 | 0.050 |
Why?
|
| Biopsy, Fine-Needle | 2 | 2006 | 1133 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3223 | 0.050 |
Why?
|
| Algorithms | 2 | 2017 | 14071 | 0.050 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2007 | 698 | 0.050 |
Why?
|
| Phagocytosis | 3 | 1998 | 1520 | 0.050 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2008 | 1224 | 0.050 |
Why?
|
| Sodium Chloride | 1 | 2004 | 576 | 0.050 |
Why?
|
| Therapeutic Irrigation | 1 | 2003 | 297 | 0.050 |
Why?
|
| Surface-Active Agents | 1 | 2002 | 150 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 4 | 1998 | 8102 | 0.050 |
Why?
|
| Gastrointestinal Diseases | 1 | 2010 | 1203 | 0.050 |
Why?
|
| Hemostatic Techniques | 1 | 2002 | 115 | 0.050 |
Why?
|
| Gallstones | 1 | 2004 | 285 | 0.050 |
Why?
|
| Tissue Donors | 2 | 2001 | 2395 | 0.050 |
Why?
|
| Follow-Up Studies | 4 | 2021 | 39193 | 0.050 |
Why?
|
| Chi-Square Distribution | 2 | 2009 | 3432 | 0.050 |
Why?
|
| Liver Regeneration | 1 | 2003 | 214 | 0.050 |
Why?
|
| Bile Duct Diseases | 1 | 2001 | 99 | 0.040 |
Why?
|
| Analgesics | 1 | 2008 | 1060 | 0.040 |
Why?
|
| Sweat Gland Neoplasms | 1 | 2002 | 110 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2018 | 5508 | 0.040 |
Why?
|
| Injections, Intralesional | 1 | 2001 | 281 | 0.040 |
Why?
|
| Hydrocephalus | 1 | 2007 | 762 | 0.040 |
Why?
|
| Cell Physiological Phenomena | 1 | 2001 | 148 | 0.040 |
Why?
|
| Infusions, Intravenous | 2 | 2002 | 2229 | 0.040 |
Why?
|
| Microspheres | 1 | 2003 | 773 | 0.040 |
Why?
|
| Practice Management | 1 | 2020 | 37 | 0.040 |
Why?
|
| Emergencies | 1 | 2006 | 1223 | 0.040 |
Why?
|
| Adenosine Triphosphatases | 1 | 2004 | 837 | 0.040 |
Why?
|
| Glucagon | 1 | 2002 | 533 | 0.040 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2008 | 953 | 0.040 |
Why?
|
| Predictive Value of Tests | 5 | 2007 | 15398 | 0.040 |
Why?
|
| Learning Curve | 1 | 2021 | 232 | 0.040 |
Why?
|
| Incidence | 3 | 2020 | 21480 | 0.040 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2002 | 373 | 0.040 |
Why?
|
| Appendectomy | 1 | 2003 | 444 | 0.040 |
Why?
|
| Monitoring, Intraoperative | 1 | 2005 | 936 | 0.040 |
Why?
|
| Neurilemmoma | 1 | 2004 | 522 | 0.040 |
Why?
|
| Health Services Research | 1 | 2006 | 1808 | 0.040 |
Why?
|
| Thyroid Gland | 1 | 2006 | 1180 | 0.040 |
Why?
|
| Endothelium | 1 | 2001 | 767 | 0.040 |
Why?
|
| Anal Canal | 1 | 2001 | 376 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2014 | 8067 | 0.040 |
Why?
|
| Hot Temperature | 2 | 2004 | 1433 | 0.040 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2005 | 1195 | 0.040 |
Why?
|
| Cholelithiasis | 1 | 2000 | 407 | 0.040 |
Why?
|
| Portography | 2 | 1995 | 11 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2014 | 3458 | 0.040 |
Why?
|
| Autoradiography | 2 | 2002 | 723 | 0.040 |
Why?
|
| Thyroid Nodule | 1 | 2006 | 779 | 0.040 |
Why?
|
| Length of Stay | 2 | 2021 | 6485 | 0.040 |
Why?
|
| Models, Theoretical | 2 | 2015 | 3564 | 0.040 |
Why?
|
| Ethanol | 2 | 2003 | 1323 | 0.040 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2000 | 236 | 0.040 |
Why?
|
| Fatty Liver | 2 | 1994 | 807 | 0.040 |
Why?
|
| Colectomy | 1 | 2003 | 697 | 0.040 |
Why?
|
| Biopsy | 2 | 2006 | 6763 | 0.040 |
Why?
|
| Reperfusion Injury | 1 | 2004 | 1042 | 0.030 |
Why?
|
| Blood Loss, Surgical | 1 | 2021 | 629 | 0.030 |
Why?
|
| Reproducibility of Results | 4 | 2009 | 20124 | 0.030 |
Why?
|
| Quality of Life | 1 | 2018 | 13462 | 0.030 |
Why?
|
| Cholangiography | 1 | 1997 | 182 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 4 | 2003 | 4034 | 0.030 |
Why?
|
| Gastrointestinal Agents | 1 | 2002 | 510 | 0.030 |
Why?
|
| Cell Communication | 1 | 2004 | 1660 | 0.030 |
Why?
|
| Postoperative Complications | 3 | 2021 | 15747 | 0.030 |
Why?
|
| Abdomen | 1 | 2003 | 1134 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2008 | 2207 | 0.030 |
Why?
|
| Mesothelioma | 1 | 2002 | 771 | 0.030 |
Why?
|
| Pyridines | 1 | 2008 | 2888 | 0.030 |
Why?
|
| Anastomosis, Surgical | 1 | 2000 | 990 | 0.030 |
Why?
|
| Postoperative Care | 1 | 2003 | 1470 | 0.030 |
Why?
|
| Prognosis | 4 | 2008 | 29922 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 2002 | 1188 | 0.030 |
Why?
|
| Peritoneal Neoplasms | 1 | 2002 | 703 | 0.030 |
Why?
|
| Epinephrine | 2 | 2004 | 783 | 0.030 |
Why?
|
| Risk Factors | 2 | 2021 | 74840 | 0.030 |
Why?
|
| Cat-Scratch Disease | 1 | 1996 | 23 | 0.030 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 1998 | 235 | 0.030 |
Why?
|
| Leukocytes | 1 | 2004 | 2027 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2012 | 6547 | 0.030 |
Why?
|
| Stomach Neoplasms | 1 | 1986 | 1471 | 0.030 |
Why?
|
| Neuroendocrine Tumors | 1 | 2002 | 654 | 0.030 |
Why?
|
| Peripheral Vascular Diseases | 1 | 1998 | 516 | 0.030 |
Why?
|
| Angina Pectoris | 2 | 1991 | 956 | 0.030 |
Why?
|
| Hemodynamics | 2 | 2004 | 4184 | 0.030 |
Why?
|
| Accident Prevention | 1 | 2015 | 76 | 0.030 |
Why?
|
| Graft Occlusion, Vascular | 1 | 1998 | 540 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2008 | 9347 | 0.030 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2004 | 1165 | 0.030 |
Why?
|
| Bronchography | 1 | 1995 | 70 | 0.030 |
Why?
|
| Laparoscopy | 1 | 2006 | 2039 | 0.030 |
Why?
|
| Phantoms, Imaging | 1 | 2003 | 2475 | 0.030 |
Why?
|
| Neurosurgical Procedures | 1 | 2005 | 2074 | 0.030 |
Why?
|
| Organizational Case Studies | 1 | 2015 | 299 | 0.030 |
Why?
|
| Optics and Photonics | 2 | 2007 | 305 | 0.030 |
Why?
|
| Galactans | 1 | 1994 | 32 | 0.030 |
Why?
|
| Systems Analysis | 1 | 2015 | 168 | 0.030 |
Why?
|
| Emergency Medical Services | 1 | 2006 | 1938 | 0.030 |
Why?
|
| Pain | 2 | 2006 | 5077 | 0.030 |
Why?
|
| Indocyanine Green | 2 | 2007 | 235 | 0.030 |
Why?
|
| Time Factors | 7 | 2006 | 40065 | 0.030 |
Why?
|
| Education, Medical | 1 | 2006 | 1746 | 0.030 |
Why?
|
| Pentetic Acid | 1 | 1994 | 208 | 0.030 |
Why?
|
| Dogs | 3 | 2004 | 3822 | 0.030 |
Why?
|
| Self-Help Groups | 1 | 2015 | 193 | 0.030 |
Why?
|
| Hemorrhage | 2 | 2004 | 3461 | 0.030 |
Why?
|
| Depression, Chemical | 2 | 1991 | 186 | 0.030 |
Why?
|
| Gallbladder Diseases | 1 | 1995 | 139 | 0.030 |
Why?
|
| Meglumine | 1 | 1994 | 143 | 0.030 |
Why?
|
| Disease Progression | 1 | 2011 | 13632 | 0.030 |
Why?
|
| Collateral Circulation | 1 | 1995 | 292 | 0.030 |
Why?
|
| Gelatin Sponge, Absorbable | 1 | 1993 | 57 | 0.030 |
Why?
|
| Systems Integration | 2 | 2005 | 427 | 0.030 |
Why?
|
| Ebstein Anomaly | 1 | 1994 | 106 | 0.030 |
Why?
|
| Propensity Score | 1 | 2021 | 1968 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2004 | 4025 | 0.030 |
Why?
|
| Fistula | 1 | 1995 | 212 | 0.030 |
Why?
|
| Varicose Veins | 2 | 1994 | 158 | 0.030 |
Why?
|
| Multiple Myeloma | 1 | 2011 | 5197 | 0.030 |
Why?
|
| Surgical Procedures, Operative | 2 | 2003 | 1941 | 0.030 |
Why?
|
| Soft Tissue Infections | 1 | 1995 | 167 | 0.030 |
Why?
|
| Massachusetts | 2 | 2021 | 8875 | 0.030 |
Why?
|
| Prospective Studies | 5 | 2018 | 54802 | 0.020 |
Why?
|
| Sex Factors | 1 | 2006 | 10603 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 1996 | 1978 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2000 | 6203 | 0.020 |
Why?
|
| Treatment Outcome | 5 | 2008 | 65188 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2007 | 10429 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2004 | 3584 | 0.020 |
Why?
|
| Physicians | 1 | 2009 | 4588 | 0.020 |
Why?
|
| Hypertension, Portal | 1 | 1993 | 229 | 0.020 |
Why?
|
| Laparotomy | 2 | 2004 | 460 | 0.020 |
Why?
|
| Sarcoma | 1 | 2002 | 1802 | 0.020 |
Why?
|
| Gadolinium DTPA | 1 | 1994 | 823 | 0.020 |
Why?
|
| Electric Conductivity | 2 | 2002 | 403 | 0.020 |
Why?
|
| Hemostasis | 1 | 1993 | 467 | 0.020 |
Why?
|
| Phosphorus | 1 | 1992 | 337 | 0.020 |
Why?
|
| Rats, Inbred ACI | 3 | 1995 | 34 | 0.020 |
Why?
|
| Nitrogen | 1 | 1992 | 346 | 0.020 |
Why?
|
| Organometallic Compounds | 1 | 1994 | 644 | 0.020 |
Why?
|
| Patient Care Planning | 1 | 1996 | 906 | 0.020 |
Why?
|
| Adrenal Medulla | 1 | 1990 | 54 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 17075 | 0.020 |
Why?
|
| Critical Illness | 1 | 2003 | 2744 | 0.020 |
Why?
|
| Carcinoma | 2 | 2004 | 2312 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2015 | 932 | 0.020 |
Why?
|
| Lung | 2 | 2005 | 10033 | 0.020 |
Why?
|
| Carcinoid Tumor | 1 | 1991 | 225 | 0.020 |
Why?
|
| Cystic Fibrosis | 1 | 1998 | 1287 | 0.020 |
Why?
|
| Age Factors | 1 | 2006 | 18380 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 1997 | 2887 | 0.020 |
Why?
|
| Causality | 1 | 2015 | 1248 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 1998 | 3404 | 0.020 |
Why?
|
| Pericardial Effusion | 1 | 1991 | 246 | 0.020 |
Why?
|
| Fluorocarbons | 1 | 1994 | 497 | 0.020 |
Why?
|
| Trachea | 1 | 1995 | 1085 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2015 | 1509 | 0.020 |
Why?
|
| Radiation Injuries | 1 | 2015 | 1181 | 0.020 |
Why?
|
| Prealbumin | 1 | 1990 | 266 | 0.020 |
Why?
|
| Drug Combinations | 1 | 1994 | 2077 | 0.020 |
Why?
|
| Magnetic Resonance Angiography | 1 | 1994 | 1426 | 0.020 |
Why?
|
| Scleroderma, Systemic | 1 | 1991 | 346 | 0.020 |
Why?
|
| Diazonium Compounds | 1 | 1987 | 17 | 0.020 |
Why?
|
| Cholangiopancreatography, Magnetic Resonance | 1 | 2008 | 101 | 0.020 |
Why?
|
| Melanoma | 2 | 2012 | 5719 | 0.020 |
Why?
|
| Back Pain | 1 | 1991 | 544 | 0.020 |
Why?
|
| Injections, Intra-Arterial | 2 | 1997 | 181 | 0.020 |
Why?
|
| Transferrin | 1 | 1988 | 283 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2003 | 8041 | 0.020 |
Why?
|
| Sodium | 1 | 1992 | 1591 | 0.020 |
Why?
|
| Species Specificity | 1 | 1991 | 2406 | 0.020 |
Why?
|
| Lymphoma | 1 | 1996 | 1897 | 0.020 |
Why?
|
| Fibrinolysis | 3 | 1993 | 331 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 1987 | 860 | 0.020 |
Why?
|
| Saliva | 1 | 1991 | 851 | 0.020 |
Why?
|
| Niacinamide | 1 | 2008 | 419 | 0.020 |
Why?
|
| Sterilization | 1 | 2006 | 133 | 0.020 |
Why?
|
| Retreatment | 1 | 2007 | 598 | 0.020 |
Why?
|
| Subarachnoid Space | 1 | 2005 | 77 | 0.020 |
Why?
|
| Electronics | 1 | 2007 | 314 | 0.020 |
Why?
|
| Blood Specimen Collection | 1 | 1987 | 238 | 0.020 |
Why?
|
| Isotope Labeling | 1 | 1987 | 389 | 0.020 |
Why?
|
| Albumins | 1 | 1988 | 577 | 0.020 |
Why?
|
| Dyspepsia | 1 | 1986 | 115 | 0.020 |
Why?
|
| Phenylurea Compounds | 1 | 2008 | 536 | 0.010 |
Why?
|
| Photomicrography | 1 | 2004 | 72 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2003 | 15880 | 0.010 |
Why?
|
| Cholecystography | 1 | 2004 | 42 | 0.010 |
Why?
|
| Transplantation, Isogeneic | 2 | 1995 | 251 | 0.010 |
Why?
|
| Lung Neoplasms | 2 | 2012 | 13451 | 0.010 |
Why?
|
| Mammography | 1 | 2015 | 2423 | 0.010 |
Why?
|
| Cerebral Ventricles | 1 | 2007 | 549 | 0.010 |
Why?
|
| Gangrene | 1 | 2004 | 92 | 0.010 |
Why?
|
| Adrenergic Agonists | 1 | 2004 | 55 | 0.010 |
Why?
|
| Arsenicals | 1 | 2004 | 117 | 0.010 |
Why?
|
| Mass Screening | 1 | 1999 | 5446 | 0.010 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2004 | 236 | 0.010 |
Why?
|
| Regression Analysis | 2 | 2004 | 6322 | 0.010 |
Why?
|
| Graft Survival | 1 | 1994 | 3890 | 0.010 |
Why?
|
| Angina, Unstable | 1 | 1987 | 893 | 0.010 |
Why?
|
| Subcutaneous Tissue | 1 | 2004 | 130 | 0.010 |
Why?
|
| Cell Biology | 1 | 2004 | 91 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 1995 | 4493 | 0.010 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2007 | 637 | 0.010 |
Why?
|
| Liver Cirrhosis | 1 | 1993 | 1959 | 0.010 |
Why?
|
| Adenosine Diphosphate | 1 | 2004 | 419 | 0.010 |
Why?
|
| Reperfusion | 2 | 1994 | 267 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2008 | 1816 | 0.010 |
Why?
|
| Bacteriological Techniques | 1 | 2004 | 276 | 0.010 |
Why?
|
| Stents | 1 | 1994 | 3213 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1992 | 3672 | 0.010 |
Why?
|
| Cholecystectomy | 1 | 2004 | 407 | 0.010 |
Why?
|
| Graft Rejection | 1 | 1995 | 4499 | 0.010 |
Why?
|
| Permeability | 1 | 2004 | 726 | 0.010 |
Why?
|
| Military Medicine | 1 | 2003 | 185 | 0.010 |
Why?
|
| Supine Position | 1 | 2002 | 209 | 0.010 |
Why?
|
| Apyrase | 1 | 2004 | 373 | 0.010 |
Why?
|
| Gastrectomy | 1 | 1986 | 694 | 0.010 |
Why?
|
| Academies and Institutes | 1 | 2003 | 326 | 0.010 |
Why?
|
| Lipoproteins, HDL | 1 | 2005 | 674 | 0.010 |
Why?
|
| Peroxidase | 1 | 2004 | 606 | 0.010 |
Why?
|
| Prone Position | 1 | 2002 | 201 | 0.010 |
Why?
|
| Cyclosporine | 1 | 2003 | 778 | 0.010 |
Why?
|
| Capillaries | 1 | 2004 | 755 | 0.010 |
Why?
|
| Platelet Activation | 1 | 2004 | 645 | 0.010 |
Why?
|
| Organ Preservation | 2 | 1994 | 399 | 0.010 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2004 | 305 | 0.010 |
Why?
|
| Cytodiagnosis | 1 | 2004 | 453 | 0.010 |
Why?
|
| Subtraction Technique | 1 | 2003 | 512 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2005 | 1831 | 0.010 |
Why?
|
| Brain | 1 | 2007 | 27171 | 0.010 |
Why?
|
| Swine | 2 | 2001 | 5988 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1992 | 5125 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2004 | 1467 | 0.010 |
Why?
|
| Audiovisual Aids | 1 | 2000 | 98 | 0.010 |
Why?
|
| Lymphatic Diseases | 1 | 2001 | 317 | 0.010 |
Why?
|
| Adolescent | 4 | 2014 | 88835 | 0.010 |
Why?
|
| Body Temperature Regulation | 1 | 2001 | 292 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 1998 | 5849 | 0.010 |
Why?
|
| Adenosine | 1 | 2004 | 806 | 0.010 |
Why?
|
| Protein Binding | 1 | 1991 | 9296 | 0.010 |
Why?
|
| Computer Systems | 1 | 2000 | 466 | 0.010 |
Why?
|
| Budgets | 1 | 2000 | 232 | 0.010 |
Why?
|
| Kidney | 2 | 2004 | 7066 | 0.010 |
Why?
|
| Digestive System Neoplasms | 1 | 1998 | 82 | 0.010 |
Why?
|
| Administration, Cutaneous | 1 | 2000 | 715 | 0.010 |
Why?
|
| Endothelium, Vascular | 2 | 2004 | 4427 | 0.010 |
Why?
|
| Intestine, Small | 1 | 2004 | 1214 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2004 | 1999 | 0.010 |
Why?
|
| Science | 1 | 2000 | 234 | 0.010 |
Why?
|
| Tail | 1 | 1997 | 91 | 0.010 |
Why?
|
| Therapy, Computer-Assisted | 1 | 1999 | 265 | 0.010 |
Why?
|
| Temperature | 1 | 2003 | 2226 | 0.010 |
Why?
|
| Spleen | 1 | 2003 | 2296 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2001 | 10729 | 0.010 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 1999 | 520 | 0.010 |
Why?
|
| Posture | 1 | 2000 | 954 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2004 | 2666 | 0.010 |
Why?
|
| Bartonella henselae | 1 | 1996 | 15 | 0.010 |
Why?
|
| Awards and Prizes | 1 | 2000 | 364 | 0.010 |
Why?
|
| Parkinson Disease | 1 | 1990 | 2895 | 0.010 |
Why?
|
| Ovarian Neoplasms | 1 | 2012 | 4900 | 0.010 |
Why?
|
| Congresses as Topic | 1 | 2000 | 811 | 0.010 |
Why?
|
| Ischemia | 1 | 2004 | 1909 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2000 | 2910 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 1987 | 4528 | 0.010 |
Why?
|
| Choline Deficiency | 1 | 1994 | 23 | 0.010 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 1994 | 64 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1995 | 26346 | 0.010 |
Why?
|
| Jugular Veins | 1 | 1995 | 211 | 0.010 |
Why?
|
| Tracheal Diseases | 1 | 1995 | 117 | 0.010 |
Why?
|
| Punctures | 1 | 1995 | 373 | 0.010 |
Why?
|
| Bronchial Diseases | 1 | 1995 | 151 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2002 | 3537 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2004 | 5881 | 0.010 |
Why?
|
| Cattle | 1 | 1999 | 3801 | 0.010 |
Why?
|
| Emulsions | 1 | 1993 | 150 | 0.010 |
Why?
|
| Rats, Inbred Lew | 1 | 1995 | 1167 | 0.010 |
Why?
|
| Blood Platelets | 1 | 2004 | 2464 | 0.010 |
Why?
|
| Iopamidol | 1 | 1993 | 188 | 0.010 |
Why?
|
| Drug Carriers | 1 | 1997 | 700 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2004 | 3513 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2004 | 3141 | 0.010 |
Why?
|
| Adenoma | 1 | 2003 | 2152 | 0.010 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 1993 | 282 | 0.010 |
Why?
|
| Clone Cells | 1 | 1996 | 1672 | 0.010 |
Why?
|
| Methionine | 1 | 1994 | 569 | 0.010 |
Why?
|
| Particle Size | 1 | 1996 | 1631 | 0.010 |
Why?
|
| Catheterization, Peripheral | 1 | 1995 | 349 | 0.010 |
Why?
|
| Microscopy, Electron | 2 | 1992 | 2548 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2004 | 9649 | 0.010 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 1991 | 123 | 0.010 |
Why?
|
| Vascular Patency | 1 | 1994 | 912 | 0.010 |
Why?
|
| Blood Coagulation Factors | 1 | 1993 | 371 | 0.010 |
Why?
|
| Scleroderma, Localized | 1 | 1991 | 85 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 1996 | 1668 | 0.010 |
Why?
|
| Bronchi | 1 | 1995 | 843 | 0.010 |
Why?
|
| Video Recording | 1 | 1996 | 969 | 0.010 |
Why?
|
| Immunodiffusion | 1 | 1990 | 140 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2003 | 4209 | 0.010 |
Why?
|
| Varicose Ulcer | 1 | 1991 | 54 | 0.010 |
Why?
|
| Densitometry | 1 | 1990 | 150 | 0.010 |
Why?
|
| Cold Temperature | 1 | 1993 | 794 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1992 | 1770 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1996 | 3089 | 0.010 |
Why?
|
| Comorbidity | 1 | 2004 | 10563 | 0.000 |
Why?
|
| Logistic Models | 1 | 2004 | 13266 | 0.000 |
Why?
|
| Periodicals as Topic | 1 | 2000 | 1462 | 0.000 |
Why?
|
| Osmolar Concentration | 1 | 1990 | 655 | 0.000 |
Why?
|
| Cytokines | 1 | 2004 | 7421 | 0.000 |
Why?
|
| Pilot Projects | 1 | 2002 | 8733 | 0.000 |
Why?
|
| Prostheses and Implants | 1 | 1995 | 1273 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2011 | 41649 | 0.000 |
Why?
|
| Fluorescent Dyes | 1 | 1996 | 1930 | 0.000 |
Why?
|
| Kidney Transplantation | 1 | 2003 | 4270 | 0.000 |
Why?
|
| Blood Coagulation | 1 | 1993 | 1166 | 0.000 |
Why?
|
| Mice, Inbred BALB C | 1 | 1996 | 6220 | 0.000 |
Why?
|
| Myocardial Infarction | 1 | 1987 | 11499 | 0.000 |
Why?
|
| Transplantation, Homologous | 1 | 1995 | 4860 | 0.000 |
Why?
|
| Cell Survival | 1 | 1996 | 5747 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 2004 | 22332 | 0.000 |
Why?
|
| Transplantation, Autologous | 1 | 1990 | 2120 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 21056 | 0.000 |
Why?
|
| Lymph Nodes | 1 | 1996 | 3454 | 0.000 |
Why?
|
| Muscle, Skeletal | 1 | 1999 | 4958 | 0.000 |
Why?
|
| Lymphocytes | 1 | 1971 | 2599 | 0.000 |
Why?
|
| Cell Line | 1 | 1996 | 15543 | 0.000 |
Why?
|
| Cell Membrane | 1 | 1971 | 3634 | 0.000 |
Why?
|
| Thrombosis | 1 | 1993 | 2949 | 0.000 |
Why?
|
| Survival Rate | 1 | 1993 | 12795 | 0.000 |
Why?
|
| Palliative Care | 1 | 1993 | 3645 | 0.000 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1993 | 9373 | 0.000 |
Why?
|
| Thorium Dioxide | 1 | 1971 | 18 | 0.000 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 1971 | 110 | 0.000 |
Why?
|
| Colloids | 1 | 1971 | 122 | 0.000 |
Why?
|
| Histological Techniques | 1 | 1971 | 193 | 0.000 |
Why?
|
| Histocytochemistry | 1 | 1971 | 696 | 0.000 |
Why?
|
| Guinea Pigs | 1 | 1971 | 1300 | 0.000 |
Why?
|
| Blood Cells | 1 | 1971 | 307 | 0.000 |
Why?
|
| Computers | 1 | 1971 | 588 | 0.000 |
Why?
|